Q Line Biotech Ltd vs Royal India Corporation Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Q-Line Biotech Ltd is ₹ 529.55 as of 23 Oct 15:30 . The P/E Ratio of Q-Line Biotech Ltd changed from 0 on March 2025 to 0 on March 2024 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Royal India Corporation Ltd changed from 9.1 on March 2025 to 0 on March 2024 . This represents a CAGR of -100.00% over 4 years The Market Cap of Q-Line Biotech Ltd changed from ₹ 0 crore on March 2025 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Royal India Corporation Ltd changed from ₹ 98.52 crore on March 2025 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 4 years The revenue of Q-Line Biotech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 110.94 crore. This represent the decline of -100% The revenue of Royal India Corporation Ltd for the Jun '26 is ₹ 5.08 crore as compare to the Mar '26 revenue of ₹ 73.81 crore. This represent the decline of -93.12% The ebitda of Q-Line Biotech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 33.57 crore. This represent the decline of -100% The ebitda of Royal India Corporation Ltd for the Jun '26 is ₹ 2.42 crore as compare to the Mar '26 ebitda of ₹ 70.19 crore. This represent the decline of -96.55% The net profit of Q-Line Biotech Ltd changed from ₹ 17.38 crore to ₹ 0 crore over 3 quarters. This represents a CAGR of -100.00% The net profit of Royal India Corporation Ltd changed from ₹ -0.38 crore to ₹ 1.93 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Q-Line Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Royal India Corporation Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Q-Line Biotech Ltd

Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand.
Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021.
Further, Company was converted from a private company to public company and the name of Company was changed to 'Q-Line Biotech Limited', via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre. The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.

About Royal India Corporation Ltd

Royal India Corporation Limited, formerly known as Natraj Financial & Services Limited was incorporated in 1984 in the name and style of Natraj Commercial Enterprises Limited.
In October 2006, Company changed its name to Natraj Financial & Services Limited.
In September, 2008, the Company was taken over by existing promoters as per the rules & regulation of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) regulations, 1997 and was again renamed to Royal India Corporation Limited in 2011. The Company evolved from being financial Services Company to a highly proactive multi-dimensional conglomerate with business interests that include Infrastructure developers, Real estate, Trading & Broking of Shares & Securities.
The Company is also engaged in the wholesale trading of Gold Bullion, plain gold jewellery, gold coins, and medallions.

FAQs for the comparison of Q-Line Biotech Ltd and Royal India Corporation Ltd

Which company has a larger market capitalization, Q-Line Biotech Ltd or Royal India Corporation Ltd?

Market cap of Q-Line Biotech Ltd is 1,235 Cr while Market cap of Royal India Corporation Ltd is 59 Cr

What are the key factors driving the stock performance of Q-Line Biotech Ltd and Royal India Corporation Ltd?

The stock performance of Q-Line Biotech Ltd and Royal India Corporation Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Q-Line Biotech Ltd and Royal India Corporation Ltd?

As of October 25, 2026, the Q-Line Biotech Ltd stock price is INR ₹529.55. On the other hand, Royal India Corporation Ltd stock price is INR ₹5.08.

How do dividend payouts of Q-Line Biotech Ltd and Royal India Corporation Ltd compare?

To compare the dividend payouts of Q-Line Biotech Ltd and Royal India Corporation Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.